Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

302
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
302
Physical Properties of Amines01:26

Physical Properties of Amines

3.2K
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
3.2K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

349
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
349
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

267
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
267
Positive Symptoms Schizophrenia: Hallucinations and Delusions01:26

Positive Symptoms Schizophrenia: Hallucinations and Delusions

107
Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
107
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

211
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
211

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Ethnicity and deprivation negatively impact the access to disease-modifying therapy for relapsing-remitting multiple sclerosis: a retrospective, single-centre study.

Journal of neurology, neurosurgery, and psychiatry·2024
Same author

Identifying co-morbidities and risk in people with epilepsy: The Maltese experience.

Epilepsy & behavior : E&B·2024
Same author

Genetic landscape of ALS in Malta based on a quinquennial analysis.

Neurobiology of aging·2022
Same author

SOD1 D91A variant in the southernmost tip of Europe: a heterozygous ALS patient resident on the island of Gozo.

European journal of human genetics : EJHG·2021
Same author

Progressive encephalomyelitis with rigidity and myoclonus (PERM).

Practical neurology·2021
Same author

Occupation and amyotrophic lateral sclerosis risk: a case-control study in the isolated island population of Malta.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2021

相关实验视频

Updated: Jul 24, 2025

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

3.4K

阿曼塔丁的毒性导致视觉幻觉.

Jessica Marie Barbara1, Adrian Pace2

  • 1Department of Medicine, Mater Dei Hospital, Msida, Malta jessica-marie.barbara@gov.mt.

Practical neurology
|July 7, 2023
PubMed
概括

用于多发性硬化症疲劳的阿曼塔丁可以在患有功能障碍的患者中引起视觉幻觉. 减少阿曼塔丁的剂量或停止服用,在患有多发性硬化症的急性脏问题患者中消除了幻觉.

科学领域:

  • 神经药理学神经药理学
  • 腎臟病學 (nephrology) 是一種醫學專業.

背景情况:

  • 阿曼塔丁是一种具有多巴胺作用的NMDA受体激活剂,用于帕金森病的动力障碍和多发性硬化症 (MS) 疲劳.
  • 脏分泌是阿曼塔丁消除的主要途径; 功能受损可以增加药物半衰期和毒性风险.

研究的目的:

  • 在患有多发性硬化症和急性功能障碍的患者中报告阿曼塔丁诱导的视觉幻觉病例.
  • 为了突出阿曼塔丁在功能受损的背景下毒性的潜力.

主要方法:

  • 一个女性多发性硬化症患者接受阿曼塔丁治疗的案例报告.
  • 临床观察与急性功能障碍一致的视觉幻觉.
  • 在停止服用药物后评估症状的消失.

主要成果:

  • 患者在阿曼塔丁治疗期间出现急性功能障碍.
  • 佛罗里达视觉幻觉与功能障碍同时出现.
  • 在停止使用阿曼塔丁后,幻觉完全消失.

结论:

  • 急性功能障碍可能会导致阿曼塔丁毒性,表现为严重的视觉幻觉.
  • 建议在给功能受损的患者开阿曼塔丁时谨慎使用.
关键词:
幻觉 幻觉 幻觉 幻觉多发性硬化症多发性硬化症

更多相关视频

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

3.5K
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

2.8K

相关实验视频

Last Updated: Jul 24, 2025

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

3.4K
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

3.5K
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

2.8K
  • 在接受阿曼塔丁治疗的患者中,监测功能至关重要,以预防不良事件.